The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
Open accessAbstract
Hepatocyte nuclear factor 4α (HNF4α) regulates genes involved in lipid and bile acid synthesis, gluconeogenesis, amino acid metabolism, and blood coagulation. In addition to its metabolic role, HNF4α is critical for hepatocyte differentiation, and loss of HNF4α is associated with hepatocellular carcinoma. The hepatocyte-specific Hnf4a knock-out mouse develops severe hepatomegaly and steatosis resulting in premature death, thereby limiting studies of the role of this transcription factor in the adult animal. In addition, gene compensation may complicate analysis of the phenotype of these mice. To overcome these issues, an acute Hnf4a knock-out mouse model was generated through use of the tamoxifen-inducible ErT2cre coupled to the serum albumin gene promoter. Microarray expression analysis revealed up-regulation of genes associated with proliferation and cell cycle control only in the acute liver-specific Hnf4α-null mouse. BrdU and ki67 staining confirmed extensive hepatocyte proliferation in this model. Proliferation was associated with induction of the hepatomitogen Bmp7 as well as reduced basal apoptotic activity. The p53/p63 apoptosis effector gene Perp was further identified as a direct HNF4α target gene. These data suggest that HNF4α maintains hepatocyte differentiation in the adult healthy liver, and its loss may directly contribute to hepatocellular carcinoma development, thus indicating this factor as a possible liver tumor suppressor gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In liver, HNF4A is required for normal development (2), including morphogenesis (3) and differentiation (4), and controls other TFs critical in liver cell fate as well as genes necessary for hepatocyte functions.”
From Hepatocyte Nuclear Factor 4‐Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver (2019) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Llovet, J. M., Burroughs, A. K., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,637
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R., Lathrop, M. G., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,610
Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107
Self-citationSladek, F. M., Zhong, W. M., Lai, E., & Darnell, J. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2353 · Cited by 1,027
Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S. G., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 975
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 850
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645
Flagged first, then by citations
2 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Saha, S. K., Parachoniak, C. A., Ghanta, K. S., Fitamant, J., Ross, K. N., Najem, M. S., Gurumurthy, S., Akbay, E. A., Sia, D., Cornellà, H., et al. (2014) · Nature · doi:10.1038/nature13441 · Cited by 460
Andrews, T. S., Atif, J., Liu, J. C., Perciani, C. T., Ma, X., Thoeni, C., Slyper, M., Eraslan, G., Segerstolpe, A., Manuel, J., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1854 · Cited by 307
Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
Snyder, E. L., Watanabe, H., Magendantz, M., Hoersch, S., Chen, T. A., Wang, D. G., Crowley, D. G., Whittaker, C. A., Meyerson, M. M., Kimura, S., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.018 · Cited by 259
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Fitamant, J., Kottakis, F., Benhamouche, S., Tian, H. S., Chuvin, N., Parachoniak, C. A., Nagle, J. M., Perera, R. M., Lapouge, M., Deshpande, V., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.027 · Cited by 248
Win, S., Than, T. A., Min, R. W. M., Aghajan, M., & Kaplowitz, N. (2016) · Hepatology · doi:10.1002/hep.28486 · Cited by 191
Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks
Babeu, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.22 · Cited by 186
Rawat, S., & Bouchard, M. J. (2014) · Journal of Virology · doi:10.1128/jvi.02440-14 · Cited by 157
Role of Hepatocyte Nuclear Factor 4α (HNF4α) in Cell Proliferation and Cancer
Walesky, C. M., & Apte, U. M. (2015) · Gene Expression · doi:10.3727/105221615x14181438356292 · Cited by 138
Désert, R., Rohart, F., Canal, F., Sicard, M., Desille, M., Renaud, S., Turlin, B., Bellaud, P., Perret, C., Clément, B., et al. (2017) · Hepatology · doi:10.1002/hep.29254 · Cited by 148
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Walesky, C. M., Edwards, G., Borude, P. C., Gunewardena, S., O’Neil, M. F., Yoo, B., & Apte, U. M. (2013) · Hepatology · doi:10.1002/hep.26251 · Cited by 130
Bruyn, T. D., Chatterjee, S., Fattah, S., Keemink, J., Nicolaï, J., Augustijns, P., & Annaert, P. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.773973 · Cited by 124
Yamashita, T., Kitao, A., Matsui, O., Hayashi, T., Nio, K., Kondo, M., Ohno, N., Miyati, T., Okada, H., Yamashita, T., et al. (2014) · Hepatology · doi:10.1002/hep.27093 · Cited by 122
Xu, Q., Li, Y., Gao, X., Kang, K., Williams, J. G., Tong, L., Liu, J., Ji, M. H., Deterding, L. J., Tong, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17818-w · Cited by 116
Sareen, D., Gowing, G., Sahabian, A., Staggenborg, K., Paradis, R., Avalos, P., Latter, J., Ornelas, L., Garcia, L., & Svendsen, C. N. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23578 · Cited by 110
Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma
Fekry, B., Ribas‐Latre, A., Baumgartner, C., Deans, J., Kwok, C., Patel, P., Fu, L., Berdeaux, R., Sun, K., Kolonin, M. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06648-6 · Cited by 108
Lü, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.003 · Cited by 106
Beggs, K. M., McGreal, S. R., McCarthy, A., Gunewardena, S., Lampe, J. N., Lau, C., & Apte, U. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.05.001 · Cited by 107
Huck, I., Gunewardena, S., Español‐Suñer, R., Willenbring, H., & Apte, U. M. (2018) · Hepatology · doi:10.1002/hep.30405 · Cited by 104
Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver
Chembazhi, U. V., Bangru, S., Hernaez, M., & Kalsotra, A. (2021) · Genome Research · doi:10.1101/gr.267013.120 · Cited by 102
Force-dependent breaching of the basement membrane
Chang, T. T., Thakar, D., & Weaver, V. M. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.12.005 · Cited by 100
Yang, F., Li, J., Zhu, J., Wang, D., Chen, S., & Bai, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.015 · Cited by 99
Barry, W. E., & Thummel, C. S. (2016) · eLife · doi:10.7554/elife.11183 · Cited by 98
Loss of liver function in chronic liver disease: An identity crisis
Berasain, C., Arechederra, M., Argemí, J., Fernández-Barrena, M. G., & Avila, M. A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.001 · Cited by 99
Walesky, C. M., Gunewardena, S., Terwilliger, E. F., Edwards, G., Borude, P. C., & Apte, U. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00064.2012 · Cited by 93
Splicing regulator SLU7 is essential for maintaining liver homeostasis
Elizalde, M., Urtasun, R., Azkona, M., Latasa, M. U., Goñi, S., García‐Irigoyen, O., Uriarte, I., Segura, V., Collantes, M., Scala, M. D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74382 · Cited by 89
Frades, I., Andréasson, E., Mato, J. M., Alexandersson, E., Matthiesen, R., & Martínez‐Chantar, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124544 · Cited by 86
An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function
Morimoto, A., Kannari, M., Tsuchida, Y., Sasaki, S., Saito, C., Matsuta, T., Maeda, T., Akiyama, M., Nakamura, T., Sakaguchi, M., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.785592 · Cited by 86
Self-citationHormonal Regulation of Liver Cytochrome P450 Enzymes
Waxman, D. J., & Chang, T. K. H. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_11 · Cited by 78
Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases
Yeh, M. M., Bosch, D. E., & Daoud, S. S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i30.4074 · Cited by 78
Yang, M., Li, S.-N., Anjum, K. M., Gui, L., Zhu, S., Liu, J., Chen, J., Liu, Q., Ye, G.-D., Wang, W., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.135053 · Cited by 77
Thakur, A., Wong, J. C. H., Wang, E. Y., Lotto, J., Kim, D., Cheng, J., Mingay, M., Cullum, R., Moudgil, V., Ahmed, N., et al. (2019) · Hepatology · doi:10.1002/hep.30631 · Cited by 68
“(11) AlbERT2creand Hnf4aFl/Fl mouse lines were described in an earlier study.(4) These two mouse strains were crossed to produce tamoxifen-inducible, hepatocyte-specific cre-recombinase–expressing mouse.”
BackgroundMethodInfluentialSelf-citationThe lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation
Battistelli, C., Sabarese, G., Santangelo, L., Montaldo, C., Gonzalez, F. J., Tripodi, M., & Cicchini, C. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0170-z · Cited by 75
Self-citationInterferons: Reprogramming the Metabolic Network against Viral Infection
Raniga, K., & Liang, C. (2018) · Viruses · doi:10.3390/v10010036 · Cited by 74
Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk
Reshef, Y. A., Finucane, H. K., Kelley, D. R., Gusev, A., Kotliar, D., Ulirsch, J. C., Hormozdiari, F., Nasser, J., O’Connor, L., van de Geijn, B., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0196-7 · Cited by 68
Yu, D., Chen, G., Pan, M., Zhang, J., He, W., Liu, Y., Nian, X., Sheng, L., & Xu, B. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26270 · Cited by 69
Nikopoulou, C., Kleinenkuhnen, N., Parekh, S., Sandoval, T., Ziegenhain, C., Schneider, F., Giavalisco, P., Donahue, K.-F., Vesting, A. J., Kirchner, M., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00513-y · Cited by 76
Zhao, J., Adams, A., Roberts, B., O’Neil, M. F., Vittal, A., Schmitt, T. M., Kumer, S. C., Cox, J., Li, Z., Weinman, S. A., et al. (2017) · Hepatology · doi:10.1002/hep.29587 · Cited by 65
Vuong, L. M., Chellappa, K., Dhahbi, J. M., Deans, J., Fang, B., Bolotin, E., Titova, N., Hoverter, N. P., Spindler, S. R., Waterman, M. L., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00030-15 · Cited by 66
Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background
Kitao, A., Matsui, O., Yoneda, N., Kozaka, K., Kobayashi, S., Koda, W., Inoue, D., Ogi, T., Yoshida, K., & Gabata, T. (2020) · European Radiology · doi:10.1007/s00330-020-06687-y · Cited by 66
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology
Dubois, V., Staels, B., Lefebvre, P., Verzi, M., & Eeckhoute, J. (2020) · Cells · doi:10.3390/cells9102185 · Cited by 63
Major roles of the circadian clock in cancer
Huang, C. L., Zhang, C., Cao, Y., Li, J., & Bi, F. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0474 · Cited by 64
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
Lee, Y., Mok, M. T. S., Kang, W., Yang, W., Tang, W., Wu, F., Xu, L., Yan, M., Yu, Z., Lee, S.-D., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky589 · Cited by 58
Regulation of hepatocyte identity and quiescence
Berasain, C., & Avila, M. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1970-7 · Cited by 64
CEACAM1 in Liver Injury, Metabolic and Immune Regulation
Horst, A. K., Najjar, S. M., Wagener, C., & Tiegs, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103110 · Cited by 63
Collapse of the hepatic gene regulatory network in the absence of FoxA factors
Reizel, Y., Morgan, A., Gao, L., Lan, Y., Manduchi, E., Waite, E. L., Wang, A. W., Wells, A., & Kaestner, K. H. (2020) · Genes & Development · doi:10.1101/gad.337691.120 · Cited by 60
Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans
Gunewardena, S., Huck, I., Walesky, C. M., Robarts, D. R., Weinman, S. A., & Apte, U. M. (2022) · Hepatology · doi:10.1002/hep.32326 · Cited by 58
Wu, H., Reizel, Y., Wang, Y. J., Lapiro, J. L., Kren, B. T., Schug, J., Rao, S. J., Morgan, A. R., Herman, A., Shekels, L. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002898117 · Cited by 53
Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation
Zhang, X. “., Jiang, T., Chen, D., Wang, Q., & Zhang, L. W. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1756219 · Cited by 57
The Dynamic Chromatin Architecture of the Regenerating Liver
Wang, A. W., Wang, Y. J., Zahm, A. M., Morgan, A. R., Wangensteen, K. J., & Kaestner, K. H. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.09.006 · Cited by 49
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
Enane, F. O., Shuen, T. W. H., Gu, X., Ebrahem, Q., Przychodzen, B. P., Makishima, H., Bodo, J., Ng, J., Chee, C. L., Ba, R., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93488 · Cited by 48
Bhushan, B., Stoops, J. W., Mars, W. M., Orr, A., Bowen, W. C., Paranjpe, S., & Michalopoulos, G. K. (2019) · Hepatology · doi:10.1002/hep.30109 · Cited by 49
Camolotto, S. A., Belova, V. K., Torre-Healy, L. A., Vahrenkamp, J. M., Berrett, K. C., Conway, H., Shea, J., Stubben, C., Moffitt, R. A., Gertz, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321316 · Cited by 46
Amicone, L., & Marchetti, A. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.04.05 · Cited by 44
Li, Z., Chen, B., Dong, W., Xu, W., Song, M., Fang, M., Guo, J., & Xu, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.07.011 · Cited by 46
Ramírez‐Tagle, R., Escobar, C. A., Romero, V., Montorfano, I., Armisén, R., Borgna, V., Jeldes, E., Pizarro, L., Simón, F., & Echeverría, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020260 · Cited by 47
Decoupling of evolutionary changes in transcription factor binding and gene expression in mammalsPreprint
Wong, E. S. W., Thybert, D., Schmitt, B. M., Stefflova, K., Odom, D. T., & Flicek, P. (2014) · Genome Research · doi:10.1101/gr.177840.114 · Cited by 46
Lee, S.-H., Veeriah, V., & Levine, F. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03862-x · Cited by 45
The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity
Amicone, L., Marchetti, A., & Cicchini, C. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02725-x · Cited by 46
HNF4α in Hepatocyte Health and Disease
Kotulkar, M., Robarts, D. R., & Apte, U. M. (2023) · Seminars in Liver Disease · doi:10.1055/a-2097-0660 · Cited by 44
Wang, Z., Li, Y., Wu, D., Yu, S., Wang, Y., & Chan, F. L. (2019) · Oncogene · doi:10.1038/s41388-019-1080-3 · Cited by 45
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Pan, X., & Zhang, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002092 · Cited by 42
Kitao, A., Matsui, O., Yoneda, N., Kozaka, K., Kobayashi, S., Koda, W., Minami, T., Inoue, D., Yoshida, K., Yamashita, T., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12911 · Cited by 39
Noce, V., Battistelli, C., Cozzolino, A. M., Consalvi, V., Cicchini, C., Strippoli, R., Tripodi, M., Marchetti, A., & Amicone, L. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2000-8 · Cited by 40
Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease
Campos, G., Schmidt‐Heck, W., Smedt, J. D., Widera, A., Ghallab, A., Pütter, L., González, D., Edlund, K., Cadenas, C., Marchan, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02630-3 · Cited by 37
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Jiménez, M., Bárcena‐Varela, M., Santamaría, E., Urtasun, R., Rodríguez‐Ortigosa, C. M., Prìeto, J., Corrales, F. J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.480 · Cited by 35
Fekry, B., Ribas‐Latre, A., Baumgartner, C., Mohamed, A. M. T., Kolonin, M. G., Sladek, F. M., Younes, M., & Eckel‐Mahan, K. L. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1277 · Cited by 35
Roberts, O. L., & Paraoan, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188393 · Cited by 35
Quintavalle, C., Hindupur, S. K., Quagliata, L., Pallante, P., Nigro, C., Condorelli, G., Andersen, J. B., Tagscherer, K. E., Roth, W., Bèguinot, F., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.512 · Cited by 34
Yamanishi, K., Doe, N., Sumida, M., Watanabe, Y., Yoshida, M., Yamamoto, H., Xu, Y., Li, W., Yamanishi, H., Okamura, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119021 · Cited by 34
Jorge-Nebert, L. F., Gálvez‐Peralta, M., Figueroa, J. A. L., Somarathna, M. S., Hojyo, S., Fukada, T., & Nebert, D. W. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu204 · Cited by 34
Piccolo, P., Annunziata, P., Soria, L. R., Attanasio, S., Barbato, A., Castello, R., Carissimo, A., Quagliata, L., Terracciano, L., & Brunetti‐Pierri, N. (2017) · Hepatology · doi:10.1002/hep.29160 · Cited by 33
Taniguchi, H., Fujimoto, A., Kono, H., Furuta, M., Fujita, M., & Nakagawa, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25456 · Cited by 32
Moore, B. D., Jin, R. U., Lo, H. G., Jung, M., Wang, H., Battle, M. A., Wollheim, C. B., Urano, F., & Mills, J. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685750 · Cited by 30
Momper, J. D., & Nigám, S. K. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1473376 · Cited by 30
Thymiakou, E., Tzardi, M. N., & Kardassis, D. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155371 · Cited by 27
Lu, R., Mucaki, E. J., & Rogan, P. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1036 · Cited by 28
Hang, H., Liu, X., Wang, H.-T., Xu, N., Bian, J., Zhang, J., Xia, L., & Xia, Q. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.020 · Cited by 28
Gopal, R., Selvarasu, K., Pandian, P. P., & Ganesan, K. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0321-0 · Cited by 27
Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver
Kazantseva, Y. A., Yarushkin, A. A., Mostovich, L. A., Pustylnyak, Y. A., & Pustylnyak, V. O. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.004 · Cited by 27
Chen, S., Liu, S., Shi, S., Jiang, Y., Cao, M., Tang, Y., Li, W., Liu, J., Fang, L., Yu, Y., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01459-0 · Cited by 33
Dillon, S. T., Bhasin, M., Feng, X., Koh, D. W., & Daoud, S. S. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-239 · Cited by 27
TRIB1 is a positive regulator of hepatocyte nuclear factor 4-alpha
Soubeyrand, S., Martinuk, A., & McPherson, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-05768-1 · Cited by 28
Joo, M. S., Koo, J. H., Kim, T. H., Kim, Y. S., & Kim, S. G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.056 · Cited by 28
Wang, Z., Li, Y., Wu, D., Yu, S., Wang, Y., & Chan, F. L. (2020) · Oncogene · doi:10.1038/s41388-020-1290-8 · Cited by 27
MicroRNAs regulating apolipoprotein B-containing lipoprotein production
Zhou, L., Irani, S., Sirwi, A., & Hussain, M. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.020 · Cited by 26
Zhang, B., Madden, P. A. F., Gu, J., Xing, X., Sankar, S., Flynn, J. A., Kroll, K. L., & Wang, T. (2017) · BMC Genomics · doi:10.1186/s12864-017-3813-4 · Cited by 27
Role of Tribbles Pseudokinase 1 (TRIB1) in human hepatocyte metabolism
Soubeyrand, S., Martinuk, A., Naing, T., Lau, P., & McPherson, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.003 · Cited by 24
Burdin, D. V., Kolobov, A. A., Brocker, C. N., Soshnev, A. A., Samusik, N., Demyanov, A. V., Brilloff, S., Jarzebska, N., Martens‐Lobenhoffer, J., Mieth, M., et al. (2016) · Scientific Reports · doi:10.1038/srep35503 · Cited by 22
Self-citationCharacterizing the Mechanism Behind the Progression of NAFLD to Hepatocellular Carcinoma
Nahon, P., Allaire, M., Nault, J., & Paradis, V. (2020) · Hepatic Oncology · doi:10.2217/hep-2020-0017 · Cited by 23
Deciphering liver zonation: New insights into the β-catenin, Tcf4, and HNF4α triad
Berasain, C., & Avila, M. A. (2014) · Hepatology · doi:10.1002/hep.27000 · Cited by 22
Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha
Lü, H., Lei, X., Liu, J. T., & Klaassen, C. D. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i4.191 · Cited by 21
Balancing metabolism and regeneration in liver diseases through HNF4α targeting
Dender, C. V., Vandewalle, J., & Libert, C. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.04.003 · Cited by 20
Huck, I., Morris, E. M., Thyfault, J., & Apte, U. (2021) · Gene Expression · doi:10.3727/105221621x16153933463538 · Cited by 20
Liver‐type fatty acid binding protein interacts with hepatocyte nuclear factor 4α
McIntosh, A. L., Petrescu, A. D., Hostetler, H. A., Kier, A. B., & Schroeder, F. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.09.043 · Cited by 20
Abou‐Alfa, G. K., Andersen, J. B., Chapman, W. C., Choti, M. A., Forbes, S. J., Gores, G. J., Hong, T. S., Harding, J. J., Heiden, M. G. V., Javle, M. M., et al. (2016) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.11.11 · Cited by 18
Characterising granuloma regression and liver recovery in a murine model of schistosomiasis japonica
Chuah, C., Jones, M. K., McManus, D. P., Nawaratna, S. S. K., Burke, M. L., Owen, H. C., Ramm, G. A., & Gobert, G. N. (2016) · International Journal for Parasitology · doi:10.1016/j.ijpara.2015.12.004 · Cited by 19
Munroe, M., Niero, E. L. D. O., Fok, W. C., Vessoni, A. T., Jeong, H., Brenner, K. A., & Batista, L. F. Z. (2020) · Hepatology · doi:10.1002/hep.31414 · Cited by 20
Lü, H., Lei, X., Guo, S., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01654-6 · Cited by 20
Ong, W., Ng, M. P.-E., Loke, S. Y., Jin, S., Wu, Y., Tanaka, K., & Wong, P. T.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068335 · Cited by 18
Metadata
- Authors
- Bonzo, J. A., Ferry, C. H., Matsubara, T., Kim, J.-H., & Gonzalez, F. J.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gonzalez, Frank J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 287
- Issue
- 10
- Pages
- 7345-7356
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3293558
- OpenAlex
- W2016456139
- Cited by
- 193
- References
- 60
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 9 · 2023: 14 · 2022: 19 · 2021: 12 · 2020: 20 · 2019: 12 · 2018: 16 · 2017: 19 · 2016: 13 · 2015: 15 · 2014: 15 · 2013: 11 · 2012: 4
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- HNF4α, hepatocyte proliferation, hepatocyte differentiation, hepatocellular carcinoma, tamoxifen-inducible Cre, BMP-7, apoptosis, PERP, transcription factors, steatosis, hepatomegaly
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Disease Models, Animal, Fatty Liver, Carcinoma, Hepatocellular, Hepatomegaly, Liver Neoplasms, Membrane Proteins, Organ Specificity, Phosphoproteins, Trans-Activators, Tumor Suppressor Protein p53, Mice, Knockout, Hepatocytes, Mice, Hepatocyte Nuclear Factor 4, Bone Morphogenetic Protein 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review